Boehringer Ingelheim and GlaxoSmithKline Back EFA's Call for Urgent Improvements in Care for People With Lung Disease This World COPD Day

General Press Releases Thursday November 19, 2009 10:01
BRUSSELS, INGELHEIM, and LONDON--19 Nov--PRNewswire-AsiaNet/InfoQuest

Boehringer Ingelheim and GSK, companies with a strong heritage in COPD (chronic obstructive pulmonary disease) and a commitment to improved patient care, have today announced their support of The European Federation of Allergy and Airways Diseases Patients' Associations' (EFA) call for urgent improvement in the care of people with COPD. To coincide with World COPD Day 2009, EFA has published a comprehensive overview of COPD in Europe, the EFA Book on COPD in Europe: Sharing and Caring, which highlights local successes and serious shortfalls in the way the disease is diagnosed and managed.

COPD is a chronic lung disease associated with a high level of mortality. According to the latest World Health Organization (WHO) estimates, 210 million people suffer from COPD and it currently ranks as the fourth leading cause of death. However, the WHO predicts that it will become the third leading cause of death worldwide by 2030. In 2005 COPD was estimated to have killed over 3 million people - more than HIV/AIDS or lung and breast cancer combined. Despite this, COPD remains a scarcely known, under- diagnosed and under-treated disease that demands a changed approach to diagnosis and treatment. Fewer than half of patients with the condition have a proper diagnosis and only 35% of patients receive a regular prescribed medication.

These issues, among others, have been highlighted by EFA who collected European data for the first time from patient groups' perspectives and are now calling for more to be done to reduce the burden of COPD and improve patient care. Over 11 million Europeans are affected by COPD and face its debilitating consequences on a daily basis.

EFA's book recognises that even in its early stages, COPD has a devastating impact on patients' quality of life as it begins to damage the lungs irreversibly causing sufferers to struggle for breath and with simple

daily tasks. In addition, patients are frustrated about the difficulty in gaining effective management of their condition including early diagnosis, education, support services and access to the best treatments available. The goal of EFA's efforts in the coming months will be to reduce the impact of COPD on patients and their caregivers and to focus efforts on a call to action for real improvements.

BI and GSK, who sponsored the project, support EFA's conclusion that there is an urgent need for a coordinated strategy of advocacy both at European and national level. To improve overall COPD management, the following four areas of focus were identified:

  • Increase the awareness of the public at large about COPD, its symptoms and risk factors in order to prevent the disease and to encourage sufferers to seek early diagnosis
  • Raise the priority of COPD with policy makers to encourage the creation of screening guidelines and mandates for early diagnosis and management of the disease
  • Improve the access to care and management for diagnosed COPD patients
  • Safeguard the respiratory health of future generations. For full version please visit
Source: Boehringer Ingelheim and GSK
-- Distributed by AsiaNet ( )--

Latest Press Release

Guangzhou: leading city in shaping urban innovation ecosystem - Guangzhou Night event ignites the Summer Davos

On the evening of September 19, the "Guangzhou Night" event, featuring the Lingnan culture, was held on the sidelines of World Economic Forum's Annual Meeting of the New Champions 2018 (Summer Davos) in Tianjin, northern China. It is the fourth year in...

Sale and sexual exploitation of children: UN rights expert launches visit to Malaysia

During an official visit to the country from 24 September to 1 October, the UN Special Rapporteur on the sale and sexual exploitation of children will examine to what extent and how Malaysia is engaged in preventing and combating these issues. "I will...

Exciting Pop-Up Dinner to Celebrate Indonesian, Thai Flavours At Nimitr

Luxury boutique hotel 137 Pillars Suites & Residences Bangkok is raising the culinary stakes with an exclusive Indonesian-Thai pop-up collaboration that goes beyond borders. Chef Nanang Prasetya Aditama of the hotel's exquisite specialty restaurant,...

October Dining Promotions At Emporium Suites by Chatrium

Emporium Suites by Chatrium is here to help you embrace iconic living with its October Dining Promotions. Here in the heart of the bustling Sukhumvit shopping and business district, invite your friends, business associates and family to share our...

St. Jude Children#s Research Hospital and Tessa Therapeutics Announce Strategic Collaboration

- The collaboration between St. Jude and Tessa aims to advance cellular immunotherapy treatments for childhood cancer - St. Jude and Tessa will pioneer a novel approach to pediatric high grade gliomas, aggressive brain cancers in children, in which...

Related Topics